MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Breast Cancer Research
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

373 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
373 works in the cohort · of 4,299,418page 2 of 8

Labels cover 0 of 373 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 373 of 373 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundunlabeled
A PALB2 mutation associated with high risk of breast cancer
Melissa C. Southey, Zhi L. Teo, James G. Dowty, Fabrice Odefrey, Daniel J. Park, Marc Tischkowitz +9 more
2010· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
114
citations
affunlabeled
Are triple-negative tumours and basal-like breast cancer synonymous?
Emad A. Rakha, David S.P. Tan, William D. Foulkes, Ian O. Ellis, Andrew Tutt, Torsten O. Nielsen +1 more
2007· letter· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
114
citations
afffundunlabeled
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
Francesca Damiola, Maroulio Pertesi, Javier Oliver, Florence Le Calvez‐Kelm, Catherine Voegele, Erin L. Young +14 more
2014· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
109
citations
afffundunlabeled
S100A7 and the progression of breast cancer
Ethan Emberley, Leigh C. Murphy, Peter H. Watson
2004· review· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
107
citations
afffundunlabeled
Tumour dormancy in breast cancer: an update
Muriel Brackstone, Jason L. Townson, Ann F. Chambers
2007· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
102
citations
afffundunlabeled
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Roger L. Milne, Mia M. Gaudet, Amanda B. Spurdle, Peter A. Fasching, Fergus J. Couch, Javier Benı́tez +75 more
2010· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
97
citations
afffundunlabeled
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
Jessica Kalra, Corinna Warburton, Karen Fang, Lincoln Edwards, Tim Daynard, Dawn Waterhouse +5 more
2009· article· en· Breast Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
74
citations
← previousnext →

How this was built: Screen · Findings · About